Dr. Vogelzang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3730 S Eastern Ave
Las Vegas, NV 89169Phone+1 702-952-3400Fax+1 702-952-3460- Is this information wrong?
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1978 - 1980
- Rush University Medical CenterFellowship, Hematology and Medical Oncology, 1977 - 1978
- Rush University Medical CenterResidency, Internal Medicine, 1974 - 1977
- University of Illinois College of MedicineClass of 1974
Certifications & Licensure
- NV State Medical License 2004 - 2023
- IL State Medical License 1975 - 2011
- MN State Medical License 1978 - 1982
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Vegas Seven Castle Connolly, 2014
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2009, 2013
- Join now to see all
Clinical Trials
- Ph II Study of Perifosine for Patients With Carcinoma of the Kidney Start of enrollment: 2007 Jul 01
- A Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Start of enrollment: 2011 Dec 01
- Phase 1 of EC1169 In Patients With Recurrent MCRPC Start of enrollment: 2014 May 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsHealth-related quality of life and pain outcomes with [Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant pr...Karim Fizazi, Ken Herrmann, Bernd J Krause, Kambiz Rahbar, Kim N Chi, Michael J Morris, Oliver Sartor, Scott T Tagawa, Ayse T Kendi, Nicholas Vogelzang, Jeremie Calais...> ;The Lancet. Oncology. 2023 Jun 1
- 5 citationsBone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with o...Primo N Lara Jr, Edward Mayerson, Erik Gertz, Catherine Tangen, Amir Goldkorn, Marta van Loan, Maha Hussain, Shilpa Gupta, Jingsong Zhang, Mamta Parikh, Przemyslaw Twa...> ;European Urology. 2024 Feb 1
- 3 citationsFirst-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic c...Karen A Autio, Celestia S Higano, Luke Nordquist, Leonard J Appleman, Tian Zhang, Xin-Hua Zhu, Hani Babiker, Nicholas J Vogelzang, Sandip M Prasad, Michael T Schweizer...> ;Journal for Immunotherapy of Cancer. 2023 Mar 1
- Join now to see all
Journal Articles
- Results of a Phase 2 Placebo-Controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–Small-Cell Lung CarcinomaBeth A Hellerstedt, Nicholas J Vogelzang, Harriet M Kluger, Christopher A Yasenchak, Michael S Gordon, Primo Lara, Clinical Lung Cancer
Authored Content
- Results of a Phase 2 Placebo-Controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–Small-Cell Lung CarcinomaOctober 2018
Press Mentions
- Transplant Recipient Offers Encouraging Message to Those Waiting: Don’t Give UpDecember 30th, 2022
- Nicholas J. Vogelzang, MD, Posthumously Receives Humanitarian Award Named in His HonorNovember 7th, 2022
- The Will to Live; Unhealthy Gut Bacteria; Promise of Genomic Testing EvolvesSeptember 23rd, 2022
- Join now to see all
Grant Support
- Zoledronate In Osteoporosis Of Prostate CancerNational Center For Research Resources2004
- Uccrc -Cancer Center Support GrantNational Cancer Institute2002–2003
- Core--Developmental FundsNational Cancer Institute2002
- Zoledronate &Osteoporotic Effects Of Androgen DeprivatiNational Center For Research Resources2000–2002
- Pharmacokinetics Of ABT-627 In Subjects With Refractory MalignanciesNational Center For Research Resources2000–2002
- Uccrc-Cancer Center Support GrantNational Cancer Institute2001
- Uccrc--Cancer Center Support GrantNational Cancer Institute1999–2001
- Prostate CancerNational Cancer Institute1996–2001
- Phase I Study Of Cep-2563 Dihydrochloride In Adults With Solid TumorsNational Center For Research Resources1998–2000
- Cancer And Leukemia Group BNational Cancer Institute1993–1998
- Phase I Trial Of Ct-1501r And High Dose IL-2 In Renal Cancer Or MelanomaNational Center For Research Resources1995
- Effect Of Food And Comparative Bioavailability Of Oral Bropirimine In CancerNational Center For Research Resources1994–1995
- Phase I Trial Of Ct-1501r And High Dose IL 2 In Renal Cancer Or MelanomaNational Center For Research Resources1994
- Cancer And LeukemiaNational Cancer Institute1989–1992
- Cancer And Leukemia Group B Grant ApplicationNational Cancer Institute1988
Professional Memberships
- Fellow
Hospital Affiliations
- Summerlin Hospital Medical CenterLas Vegas, Nevada
- Sunrise Hospital and Medical CenterLas Vegas, Nevada
- Desert Springs Hospital Medical CenterLas Vegas, Nevada
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: